Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

The natural history of human immunodeficiency virus type 1 (HIV-1) viremia and its association with clinical outcomes after seroconversion was characterized in a cohort of homosexual men. HIV-1 RNA was measured by reverse-transcription polymerase chain reaction (RT-PCR) in stored longitudinal plasma samples from 269 seroconverters. Subjects were generally antiretroviral drug naive for the first 3 years after seroconversion. The decline in CD4 lymphocyte counts was strongly associated with initial HIV RNA measurements. Both initial HIV RNA levels and slopes were associated with AIDS-free times. Median slopes were +0.18, +0.09, and -0.01 log10 copies/mL, respectively, for subjects developing AIDS <3, 3-7, and>7 years after seroconversion. In contrast, HIV RNA slopes in the 3 years preceding AIDS and HIV RNA levels at AIDS diagnosis showed little variation according to total AIDS-free time. HIV RNA load at the first HIV-seropositive visit ( approximately 3 months after seroconversion) was highly predictive of AIDS, and subsequent HIV RNA measurements showed even better prognostic discrimination.

[1]  Jeremy M. G. Taylor,et al.  A Stochastic Model for Analysis of Longitudinal AIDS Data , 1994 .

[2]  D. Cox.  Regression Models and Life-Tables , 1972 .

[3]  J J Goedert,et al.  Longitudinal HIV-1 RNA levels in a cohort of homosexual men. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[4]  R. Littell.  SAS System for Mixed Models , 1996 .

[5]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[6]  J. Goedert,et al.  Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. , 1996, JAMA.

[7]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[8]  J. Phair,et al.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.

[9]  L A Kalish,et al.  The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. , 1999, AIDS.

[10]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  J. Lundgren,et al.  Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome , 1996, AIDS.

[12]  P. Harrigan,et al.  Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons. , 1997, AIDS research and human retroviruses.

[13]  J. Margolick,et al.  Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. , 1999, The Journal of infectious diseases.

[14]  J. Margolick,et al.  Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection. , 1998, AIDS research and human retroviruses.

[15]  J J Goedert,et al.  Natural history of HIV-1 cell-free viremia. , 1995, JAMA.

[16]  P Pezzotti,et al.  Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. , 1999, The Journal of infectious diseases.

[17]  J. Margolick,et al.  Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. , 1990, Clinical immunology and immunopathology.

[18]  J. Margolick,et al.  Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma , 1999, Journal of Clinical Microbiology.

[19]  J. Margolick,et al.  Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. , 1998, JAMA.

[20]  A. Perelson,et al.  Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine , 1998, AIDS.

[21]  J. Margolick,et al.  Viability and Recovery of Peripheral Blood Mononuclear Cells Cryopreserved for up to 12 Years in a Multicenter Study , 1999, Clinical Diagnostic Laboratory Immunology.

[22]  J. Margolick,et al.  Detection of infection with human immunodeficiency virus type 1 before seroconversion: correlation with clinical symptoms and outcome. , 1997, The Journal of infectious diseases.

[23]  J. Phair,et al.  Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. , 1993, American journal of epidemiology.

[24]  A Muñoz,et al.  Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. , 1998, JAMA.

[25]  I P Keet,et al.  Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years. , 1997, The Journal of infectious diseases.

[26]  Lawrence Corey,et al.  Biological and Virologic Characteristics of Primary HIV Infection , 1998, Annals of Internal Medicine.